Clinical Trials Directory

Trials / Completed

CompletedNCT00894907

Early Goal-directed Volume Resuscitation in Severe Acute Pancreatitis

EAGLE: Early Goal-directed Volume Resuscitation in Severe Acute Pancreatitis: A Randomised Multi-centre Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
190 (estimated)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute pancreatitis (AP) is a common disorder with rising incidence varying between 35 and 80 per 100,000 in Europe and the USA. About 15% of patients develop necrotizing pancreatitis (NP) with a mortality of up to 42% and frequently prolonged hospitalisation in the survivors. Despite a fulminant pathophysiology comparable to that of sepsis, the management of NP is still re-active, symptomatic and mainly based on paradigms with low grade evidence. In sepsis beneficial effects of early goal-directed fluid resuscitation resulting in reduced mortality have been clearly shown. With regard to these data and several studies of NP demonstrating the deleterious effects of fluid loss and haemoconcentration within the first 24h after admission, early goal-directed fluid resuscitation has the potential of improving outcome also in NP. Therefore, it is the aim of this RCT to demonstrate beneficial effects of early goal-directed resuscitation using an algorithm based on modern haemodynamic parameters such as Intra-thoracic Blood Volume Index (ITBI), Extravascular Lung Water Index (ELWI) and Stroke Volume Variation (SVV) which can be easily and safely obtained due to recent progress in haemodynamic monitoring. The algorithm is aimed at maintaining adequate resuscitation (ITBI, SVV) as well as preventing pulmonary over-hydration (ELWI).The use of a similar algorithm in cardiac surgery patients resulted in a significant reduction in catecholamine use, lactate levels, duration of ventilation and ICU stay.

Detailed description

Resuscitation using crystalloids and/or colloids with the following goals: ITBI: 850 -1000 ml/sqm, if ELWI \<=12\*ml/kg 750 - 850 ml/sqm, if ELWI \>12\*ml/kg and/or PaO2:FiO2 \<200 \*ELWI \<=12ml/kg, if MAP\>65mmHg without catecholamines \<=14ml/kg, if catecholamines required for MAP\>65mmHg SVV \<10% (only in controlled ventilation and sinus rhythm) MAP \>65mmHg (MAP: Mean Arterial Pressure) IAPP \>60mmHg (IAPP: Intra-abdominal Perfusion Pressure)

Conditions

Interventions

TypeNameDescription
OTHERPiCCO-parameter-guided volume resuscitationInsertion of an arterial PiCCO catheter. Resuscitation using crystalloids and/or colloids with the following goals: ITBI: 850-1000 ml/sqm, if ELWI \<=12\*ml/kg; ITBI 750-850 ml/sqm, if ELWI \>12\*ml/kg and/or PaO2:FiO2 \<200 (\*ELWI\<=12ml/kg, if MAP\>65mmHg without catecholamines; ELWI\<=14ml/kg, if catecholamines required for MAP\>65mmHg); SVV\<10% (only in controlled ventilation and sinus rhythm); MAP\>65mmHg (MAP: Mean Arterial Pressure); IAPP \>60mmHg (IAPP: Intra-abdominal Perfusion Pressure)
OTHERControl-groupHaemodynamic management without ITBI and ELWI using any other haemodynamic monitoring tool, with the exception of the PiCCO-system. Main haemodynamic goals: CVP 8-12 mmHg; MAP \>65mmHg;IAPP \>60mmHg

Timeline

Start date
2009-08-01
Primary completion
2020-02-01
Completion
2020-05-30
First posted
2009-05-07
Last updated
2020-10-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00894907. Inclusion in this directory is not an endorsement.